Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
The Gastroprotective Effect of Hydrogen-Rich Coral Calcium in a Mouse Model of Peptic Ulcer Disease
Hung-Tsung Wu1, Ming-Tsung Hsieh2, Horng-Yih Ou1,2
1Department of Internal Medicine, School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Introduction:
Peptic ulcer disease (PUD), including gastric and duodenal ulcers, is primarily caused by Helicobacter pylori infection and non-steroid anti-inflammatory drugs, with additional contributors like stress, certain foods, and alcohol. Proton pump inhibitors (PPIs) are effective but with adverse effects, prompting the exploration of alternative therapies. Hydrogen-rich coral calcium (HRCC) is a novel antioxidative agent that exerted anti-oxidative and anti-inflammatory activities; however, the effects of HRCC on PUD were still obscure.
Methods:
The gastroprotective effects of HRCC were investigated in a mouse model of PUD, and macroscopic score was used to investigate the effects of HRCC on PUD. In addition, the expression of the pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α), C-C motif chemokine ligand 2 (Ccl2), and interleukin-6 (IL-6) by real-time quantitative polymerase chain reaction. In addition, Western blots were used to evaluate the expressions of anti-oxidative enzymes, including catalase, glutathione peroxidase-1 (GPx), and superoxide dismutase (SOD).
Results:
HRCC attenuated ulcer severity induced by ethanol and hydrogen chloride ex vivo (n = 6). In addition, long-term treatment of HRCC for seven-day reduced ethanol and hydrogen chloride-induced ulcer formation (n = 6). Moreover, we found that HRCC treatment decreased immune cell infiltration, the gene expressions of pro-inflammatory cytokines (n = 6), and enhanced antioxidative enzyme levels (n = 3) in stomach of the animals in vivo.
Conclusion:
HRCC has potential as a gastroprotective agent with anti-oxidative and anti-inflammatory activities, and its application may provide an alternative for treating PUD.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

